Gritstone bio Future Growth
Future criteria checks 2/6
Gritstone bio's earnings are forecast to decline at 1.4% per annum while its annual revenue is expected to grow at 40.5% per year. EPS is expected to grow by 8.7% per annum.
Key information
-1.4%
Earnings growth rate
8.7%
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | 40.5% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 16 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 46 | -183 | -261 | N/A | 3 |
12/31/2025 | 62 | -123 | -185 | -175 | 6 |
12/31/2024 | 37 | -125 | -153 | -121 | 7 |
12/31/2023 | 16 | -138 | -126 | -122 | N/A |
9/30/2023 | 10 | -139 | -138 | -133 | N/A |
6/30/2023 | 12 | -130 | -133 | -127 | N/A |
3/31/2023 | 15 | -125 | -128 | -123 | N/A |
12/31/2022 | 20 | -120 | -122 | -116 | N/A |
9/30/2022 | 19 | -118 | -115 | -109 | N/A |
6/30/2022 | 18 | -116 | -105 | -98 | N/A |
3/31/2022 | 16 | -112 | -101 | -95 | N/A |
12/31/2021 | 48 | -75 | -56 | -51 | N/A |
9/30/2021 | 46 | -72 | -57 | -52 | N/A |
6/30/2021 | 45 | -70 | -61 | -57 | N/A |
3/31/2021 | 42 | -71 | -58 | -55 | N/A |
12/31/2020 | 4 | -105 | -93 | -89 | N/A |
9/30/2020 | 4 | -106 | -95 | -86 | N/A |
6/30/2020 | 4 | -107 | -105 | -91 | N/A |
3/31/2020 | 4 | -103 | -104 | -89 | N/A |
12/31/2019 | 4 | -94 | -101 | -85 | N/A |
9/30/2019 | 5 | -84 | -88 | -76 | N/A |
6/30/2019 | 4 | -75 | -56 | -49 | N/A |
3/31/2019 | 3 | -69 | -49 | -42 | N/A |
12/31/2018 | 1 | -65 | -44 | -38 | N/A |
9/30/2018 | 0 | -65 | -46 | -40 | N/A |
6/30/2018 | N/A | -56 | -60 | -49 | N/A |
3/31/2018 | N/A | -47 | -55 | -44 | N/A |
12/31/2017 | N/A | -41 | -46 | -35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2JQ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2JQ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2JQ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2JQ's revenue (40.5% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 2JQ's revenue (40.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2JQ's Return on Equity is forecast to be high in 3 years time